SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wanbury completes USFDA inspection at Tanuku Plant with 5 observations

06 Mar 2018 Evaluate

Wanbury has completed the United States Food and Drug Administration (USFDA) inspection at its major API facility in Tanuku Plant, Andhra Pradesh with five observations. The same is being addressed and will be resolved by the Regulatory Team.  The audit was carried out for a period of 5 days and concluded on March 2, 2018.

Wanbury is a pharmaceutical company and offers active pharmaceutical ingredient (API) in over 70 countries.


Wanbury Share Price

259.05 -6.90 (-2.59%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×